Bill Aims to Protect Patient Access to Medication Information

April 3, 2023 by Dan McCue
Bill Aims to Protect Patient Access to Medication Information
Rep. Jared Golden, D-Maine

WASHINGTON — A bill introduced by Rep. Jared Golden, D-Maine, aims to ensure that rural Americans and senior citizens have access to information about their prescription medications — even without internet access.

“Many rural Mainers and seniors don’t have reliable access to the internet or aren’t comfortable using it to get important information about their prescription medications,” Golden said as he explained the motivation behind the Patients’ Right to Know Their Medication Act of 2023.

“Our bipartisan bill requires information about medications to be printed, ensuring that every American who relies on a prescription has all the information they need to take it safely when they leave the pharmacy,” he continued, adding, “This commonsense bill also would support hundreds of good jobs in Madawaska and our state’s forest products industry.” 

Joining Golden in sponsoring the bill are Reps. Buddy Carter, R-Ga., Dutch Ruppersberger, D-Md., and Bruce Westerman, R-Ark. 

Pharmacies often provide printed medication information for patients; however, they are not required to do so under current law, the representatives said.

As a result, some patients never receive important information on the safety, dosage and other details of their prescriptions with important health consequences. 

Printed information is particularly important in rural areas where internet access is often unreliable and for senior populations who don’t regularly use computers. 

The introduction of this bill also marks another step in the fight to protect the hundreds of good-paying Maine jobs at the Twin Rivers Paper Company’s Madawaska Paper Mill. 

In 2021, Golden successfully worked to defeat an amendment backed by the pharmaceutical lobby that would have required prescription drug manufacturers to distribute information electronically rather than include a paper insert. 

Twin Rivers Paper in Madawaska is the leading manufacturer of the paper inserts and employs over 500 people.

The Patients’ Right to Know Their Medication Act has been referred to the House Committee on Energy and Commerce.

Dan can be reached at [email protected] and @DanMcCue

A+
a-
  • access to information
  • Jared Golden
  • labeling
  • packaging
  • prescription drugs
  • In The News

    Health

    Voting

    Prescription Drugs

    What Do Weight Loss Drugs Mean for a Diet Industry Built on Eating Less and Exercising More?

    NEW YORK (AP) — Ever since college, Brad Jobling struggled with his weight, fluctuating between a low of 155 pounds... Read More

    NEW YORK (AP) — Ever since college, Brad Jobling struggled with his weight, fluctuating between a low of 155 pounds when he was in his 30s to as high as 220. He spent a decade tracking calories on WeightWatchers, but the pounds he dropped always crept... Read More

    April 24, 2024
    by Dan McCue
    FDA Approves New Treatment for Urinary Tract Infections

    WASHINGTON — The Food and Drug Administration approved Pivya (pivmecillinam) tablets for the treatment of female adults with uncomplicated urinary... Read More

    WASHINGTON — The Food and Drug Administration approved Pivya (pivmecillinam) tablets for the treatment of female adults with uncomplicated urinary tract infections.  “Uncomplicated UTIs are a very common condition impacting women and one of the most frequent reasons for antibiotic use,” said Dr. Peter Kim, M.S.,... Read More

    April 23, 2024
    by Beth McCue
    Study Finds Next-Gen Antibiotics Underutilized

    WASHINGTON — A new study conducted by researchers at the National Institutes of Health found clinicians frequently continue to treat... Read More

    WASHINGTON — A new study conducted by researchers at the National Institutes of Health found clinicians frequently continue to treat antibiotic-resistant infections with older generic antibiotics considered to be less effective and less safe than newer ones. Researchers examined the factors influencing doctors’ preference for older... Read More

    April 17, 2024
    by Dan McCue
    Eli Lilly Obesity Drug Appears to Ease Sleep Apnea Symptoms in Trials

    WASHINGTON — A pair of yearlong clinical trials conducted by the drug maker Eli Lilly appear to show that its... Read More

    WASHINGTON — A pair of yearlong clinical trials conducted by the drug maker Eli Lilly appear to show that its obesity drug, Zepbound, can provide considerable relief to overweight people who have sleep apnea. Though the findings have yet to be published in a peer-reviewed medical... Read More

    Many Cancer Drugs Remain Unproven Five Years After Accelerated Approval, a Study Finds

    The U.S. Food and Drug Administration’s accelerated approval program is meant to give patients early access to promising drugs. But how often... Read More

    The U.S. Food and Drug Administration’s accelerated approval program is meant to give patients early access to promising drugs. But how often do these drugs actually improve or extend patients’ lives? In a new study, researchers found that most cancer drugs granted accelerated approval do not demonstrate such... Read More

    ALS Drug Will Be Pulled From US Market After Study Showed Patients Didn't Benefit

    WASHINGTON (AP) — The maker of a drug for Lou Gehrig’s disease that recently failed in a large study said Thursday it... Read More

    WASHINGTON (AP) — The maker of a drug for Lou Gehrig’s disease that recently failed in a large study said Thursday it will pull the medicine from the market, acknowledging it didn't help patients with the deadly neurological condition. Amylyx Pharmaceuticals announced it will voluntarily halt sales and... Read More

    News From The Well
    scroll top